白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
JOURNAL OF LEUKEMIA & LYMPHOMA
2009年
2期
123-127
,共5页
树突状细胞%白血病%抗原
樹突狀細胞%白血病%抗原
수돌상세포%백혈병%항원
Dendritic cell%Leukemia%Antigen
树突状细胞(DC)是介导T细胞免疫应答的有力启动细胞,白血病来源DC同样具有抗原提呈及摄取能力.用肿瘤抗原冲击DC在体外、体内能够有效地触发T细胞免疫应答,成为肿瘤特异性细胞毒性T细胞.介绍了DC的生物学特性、肿瘤免疫、白血病细胞的肿瘤逃逸机制以及DC在白血病免疫治疗中的研究进展情况.
樹突狀細胞(DC)是介導T細胞免疫應答的有力啟動細胞,白血病來源DC同樣具有抗原提呈及攝取能力.用腫瘤抗原遲擊DC在體外、體內能夠有效地觸髮T細胞免疫應答,成為腫瘤特異性細胞毒性T細胞.介紹瞭DC的生物學特性、腫瘤免疫、白血病細胞的腫瘤逃逸機製以及DC在白血病免疫治療中的研究進展情況.
수돌상세포(DC)시개도T세포면역응답적유력계동세포,백혈병래원DC동양구유항원제정급섭취능력.용종류항원충격DC재체외、체내능구유효지촉발T세포면역응답,성위종류특이성세포독성T세포.개소료DC적생물학특성、종류면역、백혈병세포적종류도일궤제이급DC재백혈병면역치료중적연구진전정황.
Dendritic cells are the most powerful cells to induce T cell immune reaction. DC derived from leukemia also possess the ability of the antigen processing and presentation. DC pulsed with tumor antigen can effectively initiate T cell immune reaction and induce T cell to cytotoxic T lymphocytes in vitro and in vivo. In this text, we introduce the advanced development of the biological character of DC, tumor immunology, the mechanism of tumor cell escaping immune surveillance and DC in leukemia immunotherapy.